These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 21682014
1. Strontium ranelate: too many adverse effects. Prescrire Int; 2011 Jun; 20(117):154. PubMed ID: 21682014 [No Abstract] [Full Text] [Related]
2. Interstitial granulomatous reaction to strontium ranelate. Groves C, McMenamin ME, Casey M, Barnes L. Arch Dermatol; 2008 Feb; 144(2):268-9. PubMed ID: 18283194 [No Abstract] [Full Text] [Related]
3. Generalized cutaneous drug eruption due to strontium ranelate. Boada A, Carrascosa JM, Leal L, Ferrándiz C. J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):321-2. PubMed ID: 18624862 [No Abstract] [Full Text] [Related]
8. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis. Hwang JS, Chen JF, Yang TS, Wu DJ, Tsai KS, Ho C, Wu CH, Su SL, Wang CJ, Tu ST. Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436 [Abstract] [Full Text] [Related]
9. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis. Adami S. Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247 [Abstract] [Full Text] [Related]
10. Strontium ranelate: the first agent of a new therapeutic class in osteoporosis. Neuprez A, Hiligsmann M, Scholtissen S, Bruyere O, Reginster JY. Adv Ther; 2008 Dec; 25(12):1235-56. PubMed ID: 19066755 [Abstract] [Full Text] [Related]
11. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Namazi H. Curr Med Res Opin; 2012 Apr; 28(4):609; author reply 609-10. PubMed ID: 22435797 [No Abstract] [Full Text] [Related]
12. Bullous DRESS in a patient on strontium ranelate. Kramkimel N, Sibon C, Le Beller C, Saiag P, Mahé E. Clin Exp Dermatol; 2009 Oct; 34(7):e349-50. PubMed ID: 19456761 [No Abstract] [Full Text] [Related]
13. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years. Reginster JY, Bruyère O, Sawicki A, Roces-Varela A, Fardellone P, Roberts A, Devogelaer JP. Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207 [Abstract] [Full Text] [Related]
14. Strontium ranelate may cause alopecia. Sainz M, del Pozo JG, Arias LH, Carvajal A. BMJ; 2009 Apr 22; 338():b1494. PubMed ID: 19386675 [No Abstract] [Full Text] [Related]
15. Strontium ranelate in the prevention of osteoporotic fractures. Reginster JY, Malaise O, Neuprez A, Bruyere O. Int J Clin Pract; 2007 Feb 22; 61(2):324-8. PubMed ID: 17263720 [Abstract] [Full Text] [Related]
16. Strontium ranelate as a cause of acute renal failure and dress syndrome. Iyer D, Buggy Y, O'Reilly K, Searle M. Nephrology (Carlton); 2009 Sep 22; 14(6):624. PubMed ID: 19712264 [No Abstract] [Full Text] [Related]
17. Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction. Smith EV, Shipley DR. Age Ageing; 2010 May 22; 39(3):401-3. PubMed ID: 20299323 [Abstract] [Full Text] [Related]
19. Strontium ranelate-induced DRESS syndrome with persistent autoimmune hepatitis. Kinyó Á, Belso N, Nagy N, Pálvölgyi A, Nagy I, Korom I, Varga E, Kemény L, Bata-Csörgo Z. Acta Derm Venereol; 2011 Mar 22; 91(2):205-6. PubMed ID: 21243321 [No Abstract] [Full Text] [Related]